India  
 
NewsR.in

Serum Institute of India

Indian biotechnological company, vaccine manufacturer

Serum Institute of India    ▸ Facts   ▸ Comments   ▸ News   ▸ Videos   

Serum Institute of India: Indian biotechnological company, vaccine manufacturer
Serum Institute of India is an Indian biotechnology and pharmaceuticals company. It is the world's largest vaccine manufacturer. It is located in the city of Pune, India, and was founded by Cyrus Poonawalla in 1966. The company is a subsidiary of the holding company Poonawalla Investment and Industries.

0
shares		ShareTweetSavePostSend
 

Covid vaccine: How many Indians got jab on Day 1? Govt reveals [Video]

Covid vaccine: How many Indians got jab on Day 1? Govt reveals

At least 1,65,714 healthcare beneficiaries received COVID-19 jab on Saturday across India, marking it as a historic and biggest COVID-19 vaccination drive launched by Prime Minister Narendra Modi...

Credit: HT Digital Content     Duration: 06:46Published
First feeling, side-effects, doubts: Vaccinated doctors share experience [Video]

First feeling, side-effects, doubts: Vaccinated doctors share experience

On Day 1 of India's Covid-19 vaccination, two doctors who took the shots shared their experience. Dr Atul Peters and Anil Dhar of Max hospital were given Bharat Biotech's Covaxin and SII-made..

Credit: HT Digital Content     Duration: 08:15Published
Nepal: People cheers after approval of Covishield vaccine manufactured in India [Video]

Nepal: People cheers after approval of Covishield vaccine manufactured in India

After Nepal government approved emergency use of Covishield vaccine, people are hoping the pandemic will falter and human lives would be back on track. Nepal's Department of Drug Administration on..

Credit: ANI     Duration: 02:39Published
Watch: SII CEO Poonawalla receives shot of Covishield vaccine [Video]

Watch: SII CEO Poonawalla receives shot of Covishield vaccine

Serum Institute of India (SII), CEO Adar Poonawalla received a COVISHIELD vaccine shot on January 16. COVISHIELD vaccine is manufactured by SII. India has approved 2 vaccines - Covishield and Covaxin...

Credit: ANI     Duration: 01:08Published
COVID-19 vaccination drive begins in India [Video]

COVID-19 vaccination drive begins in India

The mega COVID-19 vaccination drive began in India on January 16. Prime Minister Narendra Modi launched the drive and around 100 healthcare workers will get vaccinated at each session site on the..

Credit: ANI     Duration: 01:41Published
'Beginning of the end of Covid-19': Harsh Vardhan on India's vaccination drive [Video]

'Beginning of the end of Covid-19': Harsh Vardhan on India's vaccination drive

Union health minister Dr Harsh Vardhan said that the vaccination drive is 'beginning of the end of covid-19'. He reviewed the preparedness ahead of the Covid-19 vaccination drive in India. "World's..

Credit: HT Digital Content     Duration: 03:02Published
COVID vaccine reaches length and breadth of country [Video]

COVID vaccine reaches length and breadth of country

As India is set to start the vaccination program against COVID-19 on January 16, millions of doses of Covishield vaccine, manufactured by Pune's Serum Institute of India, have reached the length and..

Credit: ANI     Duration: 02:57Published
Over 3 lakh Covisheild doses reach Raipur [Video]

Over 3 lakh Covisheild doses reach Raipur

A consignment of COVID-19 vaccine, Covishield arrived at Raipur from Serum Institute of India, Pune on January 13. SII had dispatched vaccines across India on January 12. Raipur received 23, 300 vials..

Credit: ANI     Duration: 01:37Published
Jammu, Kanpur receive Covisheild vaccine [Video]

Jammu, Kanpur receive Covisheild vaccine

A consignment of COVID-19 vaccine, Covishield arrived at Jammu airport from Serum Institute of India, Pune on January 13. Covishield vaccines were shifted to the storage rooms. Kanpur also received its..

Credit: ANI     Duration: 02:01Published
Covisheild vaccine reaches Kochi [Video]

Covisheild vaccine reaches Kochi

A consignment of COVID-19 vaccine, Covishield arrived at Kochi airport from Serum Institute of India, Pune on January 13. Vaccine consignments were shifted to Ernakulam General Hospital. SII had..

Credit: ANI     Duration: 01:39Published
Free Covid vaccine for Delhi residents? CM Kejriwal comments ahead of launch [Video]

Free Covid vaccine for Delhi residents? CM Kejriwal comments ahead of launch

Delhi Chief Minister Arvind Kejriwal commented on the impending launch of mass immunisation against Covid-19. India will begin vaccinations on January 16. Vaccines are being shipped to various centres..

Credit: HT Digital Content     Duration: 02:39Published
5.06 lakh doses of Covishield vaccine arrives at Bhopal airport [Video]

5.06 lakh doses of Covishield vaccine arrives at Bhopal airport

A consignment of COVID-19 vaccine, Covishield arrived at Bhopal airport from Serum Institute of India, Pune. "We have received 5.06 lakh doses of vaccine. We have made 1,200 storage systems at state..

Credit: ANI     Duration: 01:41Published
Watch: 1st batch of Covaxin reaches Delhi; Mumbai receives Covishield [Video]

Watch: 1st batch of Covaxin reaches Delhi; Mumbai receives Covishield

The first batch of Covaxin landed at the Delhi airport from Hyderabad on January 13. The Covid-19 vaccine by Bharat Biotech was brought in by two flights. An Air India flight landed with 3 boxes while..

Credit: HT Digital Content     Duration: 02:02Published
First batch of 'Covishield' arrives in Mumbai [Video]

First batch of 'Covishield' arrives in Mumbai

The first consignment of 'Covishield', the COVID-19 vaccine by Serum Institute of India (SII) arrived in Mumbai on January 13. The vaccine was brought from Pune in a special vehicle of Brihanmumbai..

Credit: ANI     Duration: 01:21Published

You Might Like


India may get four more COVID-19 vaccines soon, SII says work in progress

According to Suresh Jadhav, Executive Director of the Serum Institute, work is progressing rapidly on four more vaccines in addition to Covishield.
DNA - Published

India plans 20 million doses of vaccine supply to neighbours

India plans to offer 20 million doses of coronavirus vaccine to its neighbours as it draws up a policy to supply vials to countries across the globe, people with knowledge of the matter said. An Indian..
IndiaTimes - Published

Serum Institute expects WHO emergency approval for AstraZeneca shot soon

The Serum Institute of India expects WHO emergency-use authorization soon for the Oxford University/AstraZeneca coronavirus vaccine, which it is producing for mid and low income countries, its chief..
IndiaTimes - Published

Experts question govt vaccine purchase price, say it’s higher

As the Covid-19 vaccine completes its journey from laboratory to hospital, its pricing is being questioned. Public health activists and industry experts to whom TOI spoke said the government’s..
IndiaTimes - Published

Vaccine drive accelerates, doses reach far corners of India

While SII moved about 56 lakh doses of Covishield to 13 cities, Hyderabad-based Bharat Biotech said it had successfully transported the indigenous Covaxin, developed in collaboration with the ICMR and..
IndiaTimes - Published

J&K receives 1.46 lakh doses of coronavirus vaccine

Jammu and Kashmir on Wednesday received the first consignment of 1.46 lakh doses of coronavirus vaccine from Pune-based Serum Institute of India (SII), officials said. While 79,000 doses were received..
IndiaTimes - Published

India’s biggest vaccine rollout begins as SII ships 55 lakh doses

Delhi, Chennai, Kolkata and Hyderabad, the four major regional depots for Covid-19 vaccines, received their quantum of Covishield doses within 10 hours since their dispatch began from the SII premises..
IndiaTimes - Published

COVID-19: Serum Institute CEO Adar Poonawalla reveals cost of Covishield vaccine in private markets - Check price here

Serum Institute of India CEO Adar Poonawalla on Tuesday (January 12) said that 'Covishield' will be made available in private markets at Rs 1,000.
DNA - Published

54.72 lakh Covid-19 vaccine doses received till Tuesday afternoon: Centre

The Centre said 54.72 lakh Covid-19 vaccine doses have been received at designated national and state-level stores till Tuesday afternoon, and all the shots -- 1.1 crore from the Serum Institute of..
IndiaTimes - Published

Covishield dispatch for vaccine drive a historic moment: Serum Institute of India


IndiaTimes - Published

Covishield to cost Rs 1000 per vial in private market: SII CEO Adar Poonawalla

"We have given a special price of Rs 200 for the first 100 million doses only to the Government of India on their request, because we want to support common man, vulnerable, poor and healthcare..
IndiaTimes - Published

Government committed to buy another 4.5 crore doses of Covishield vaccine

The government has committed to buy from the Serum Institute further 4.5 crore doses of Oxford Covid-19 vaccine, Covishield, at a price of Rs 200 per shot plus applicable taxes by April, in addition to..
IndiaTimes - Published

First Covishield vaccines consignment leaves Serum Institute

A decisive phase in India's fight against coronavirus began in the wee hours on Tuesday as the first consignment of Covishield vaccines left Serum Institute of India for Pune airport, four days ahead..
IndiaTimes - Published

SII gets order for 11 million vaccine doses, trucks ready for transportation

The process of transporting Covishield vaccine began on Monday after the Serum Institute of India (SII) received the Centre’s initial purchase order for 11 million doses at Rs 200 per dose. This..
IndiaTimes - Published

India wants Serum Institute to lower price of AstraZeneca shot, say sources

The Indian government has been negotiating with the Serum Institute of India to bring down the price of AstraZeneca's Covid-19 vaccine, delaying the roll-out of the country's immunisation programme...
IndiaTimes - Published

Vaccine transport from Serum Institute to start on Jan 11 or 12: Sources


IndiaTimes - Published

Brazil President Jair Bolsonaro writes to PM for 2m Covishield doses

With Covid cases in Brazil topping 8 million, its President Jair Bolsonaro wrote a letter to PM Modi this week asking for 2 million Covishield vaccines manufactured by Serum Institute. Brazil, he said,..
IndiaTimes - Published

Serum’s vaccine despatch delayed another 48 hours

The massive airlift of the Covishield vaccine doses from here has been delayed by another 48 hours. It is now likely to happen only by Monday. Vaccine manufacturer Serum Institute of India has..
IndiaTimes - Published

Vaccine take-off from Pune waits for govt to place order

Pune airport was ready on Thursday night to begin facilitating a massive airlift of Covid-19 vaccines, perhaps the largest such exercise in the world, but its manufacturer here, Serum Institute of..
IndiaTimes - Published

Brazil dials India on Covid vaccine imports

India’s vaccine diplomacy push might be impacted by confusing signals on the export of vaccines. On Monday, the Jair Bolsonaro government in Brazil dialled the Indian government after the chief of..
IndiaTimes - Published

All-India vaccine rollout set for next week: Govt

The government will roll out the Covid-19 vaccine next week, with health secretary Rajesh Bhushan saying this was set to happen within 10 days of emergency use authorisation being granted. The Indian..
IndiaTimes - Published

Bharat Biotech, Serum Institute pledge for smooth rollout of Covid-19 vaccines

Vaccine makers Serum Institute of India and Bharat Biotech on Tuesday said both the companies jointly pledge for smooth roll out of Covid-19 vaccines in the country and the world.
IndiaTimes - Published

Centre taking up Covid-19 vaccination in a big way: Harsh Vardhan

Union health and family welfare minister Dr Harsh Vardhan on Monday said the Centre has initiated a series of actions to prevent the spread of coronavirus and that it is now taking up the vaccination..
IndiaTimes - Published

Like Putin and Joe Biden, PM Modi should also get the first vaccine shot, says Cong leader

The DCGI on Sunday approved Serum Institute of India's 'Covishield' vaccine and Bharat Biotech's 'Covaxin' for emergency use.
DNA - Published

Coronavirus vaccine price: SII CEO reveals how much it will cost

COVID-19 vaccines of Serum Institue of India and Bharat Biotech were granted permission for restricted use in an emergency situation on Sunday.
DNA - Published

Private hospitals, companies may get vaccine by March: Serum CEO

SII, once it rolls out the 50-60 million doses of Covishield that forms the first tranche of the govt's order, will give doses to private individuals, private hospitals and companies as early as March,..
IndiaTimes - Published

Serum Institute says to meet local demand for AstraZeneca vaccine for next two months before exporting

Serum Institute of India (SII), the local maker of the AstraZeneca/Oxford coronavirus vaccine, said on Sunday it intends to concentrate on meeting India's own immediate demand in the next two months..
IndiaTimes - Published

WHO welcomes India's emergency use authorisation approval to COVID-19 vaccines

The COVID-19 vaccines of the Serum Institute of India and Bharat Biotech have been granted permission for restricted use in an emergency situation.
DNA - Published

'Watershed moment in India's battle against COVID': Politicos react over emergency use approval

DCGI approved Covishield, manufactured by the Serum Institute, and indigenously developed Covaxin of Bharat Biotech for restricted emergency use.
DNA - Published

Covishield COVID-19 vaccine ready to roll out in coming weeks: SII's Adar Poonawalla

Poonawalla's remarks came soon after DCGI approved Serum Institute's 'Covishield' vaccine for restricted emergency use in India.
DNA - Published

BREAKING: DCGI grants approval to Serum Institute, Bharat Biotech's COVID-19 vaccines

The approval comes after the clearances from the Subject Expert Committee (SEC).
DNA - Published

Bharat Biotech’s Covaxin too gets nod for emergency use

India's vaccine rollout will begin with the availability of two jabs- Oxford-Astra Zeneca's Covishield and Bharat Biotech's homegrown Covaxin- with the Drugs Controller General of India expected to..
IndiaTimes - Published

After Covishield, India's Covaxin gets expert panel nod for emergency use

An expert panel of India's drug authority on Saturday recommended restricted emergency use of Bharat Biotech's Covaxin. The development comes a day after the panel recommended emergency use..
IndiaTimes - Published

Happy New Year: Expert panel clears Oxford vaccine for India

India moved closer to the rollout of its vaccination plan against Covid-19 with the subject expert committee of the drug regulator on Friday recommending emergency-use authorisation (EUA) for Serum..
IndiaTimes - Published

India set to approve its first Covid vaccine; nationwide dry run tomorrow

A day ahead of the nationwide Covid-19 vaccination dry run, the Indian drug regulator's expert panel on Friday cleared the decks for emergency use authorisation for the vaccine developed by AstraZeneca..
IndiaTimes - Published

UK approves Oxford vaccine, raising hopes for India rollout

India's subject expert committee that met on Wednesday sought more data relating to the vaccine's immunogenicity, which will mean the emergency-use approval may take a few more days. The committee is..
IndiaTimes - Published

India's drug regulator to meet again on January 1 to discuss AstraZeneca vaccine

CDSCO, India's drug regulator will meet on Friday to consider approving AstraZeneca and Oxford University's Covid-19 vaccine for emergency use. SII, the world's biggest vaccine producer, has already..
IndiaTimes - Published

UK approval of Oxford-AstraZeneca Covid-19 vaccine positive news, waiting for India's approval: Serum Institute


IndiaTimes - Published

Expert committee to consider Serum Institute's request for emergency vaccine use


IndiaTimes - Published

Covid-19: 40-50m shots stockpiled by SII, India to get most of it

India will initially get most of the 40-50 million ‘Covishield’ vaccine shots stockpiled by the Serum Institute of India (SII), since exports would require the World Health Organisation’s..
IndiaTimes - Published

Union health minister Harsh Vardhan launches India's first indigenously developed pneumococcal vaccine 'Pneumosil'

Union health minister Harsh Vardhan on Monday launched the country's first pneumococcal conjugate vaccine 'Pneumosil' developed by Serum Institute of India in collaboration with partners like the Bill..
IndiaTimes - Published

Expecting Covid vaccine approval soon; 50 million doses ready: Serum Institute CEO


IndiaTimes - Published

Covid-19: Oxford vaccine may get nod in a few days

India is likely to see the Oxford-AstraZeneca vaccine being approved for emergency use in next few days as the updated data submitted by Serum Institute of India (SII) appears “satisfactory”, top..
IndiaTimes - Published

COVID-19 vaccine manufacturers must be protected from lawsuits: SII CEO Adar Poonawalla

Poonawalla made these comments at an online panel on the challenges of developing a COVID-19 vaccine at the Carnegie India's Global Technology Summit
DNA - Published

COVID vaccine distribution requires funding of Rs 80,000 crore, says Serum Institute of India

Serum Institute-Oxford's Covishield, Bharat Biotech's Covaxin and Pfizer vaccine are in the fray for emergency use authorization.
DNA - Published

India requires Rs 80,000 crore for vaccine distribution next year: SII

NEW DELHI: Pune-based vaccine-maker Serum Institute of India, which has partnered with AstraZeneca to manufacture the Oxford-AstraZeneca vaccine, on Saturday said that the country would require a..
IndiaTimes - Published

India may commence COVID-19 vaccination drive by Jan, normal life will resume by Oct: SII CEO Adar Poonawalla

Adar Poonawala said that the government wants to procure 300-400 million doses by July 2021
DNA - Published

Covid-19: Serum Institute of India to get India nod soon after UK approval


IndiaTimes - Published

Covid-19: Vaccine makers asked to submit more data

The drug regulator has asked Bharat Biotech and Serum Institute of India (SII), which have sought emergency use authorisation (EUA) for their anti-Covid vaccines, to submit updated safety and..
IndiaTimes - Published

CDSCO expert panel seeks more data on Covid-19 vaccines from Serum Institute, Bharat Biotech

An expert committee of the Central Drugs Standard Control Organisation (CDSCO) on Wednesday sought additional safety and efficacy data for Covid-19 vaccine candidates of Serum Institute and Bharat..
IndiaTimes - Published


 Page 1  〉